Sign In
Buy LH
$258.92
+1.22 (+0.473%)
At Close: Jun 03, 2026
Labcorp Holdings Inc. (LH) Q1 2026 Earnings Call Transcript
12:41pm, Thursday, 30'th Apr 2026
Labcorp Holdings Inc. (LH) Q1 2026 Earnings Call Transcript
Labcorp Advances As AI Investments, Core Businesses Drive Growth
12:05pm, Thursday, 30'th Apr 2026
Labcorp Holdings (NYSE:LH) shares are up, up 1.46%, on Thursday as the company reported strong first-quarter results and raised its full-year guidance.
Here's Why Labcorp Holdings (LH) is a Strong Value Stock
10:40am, Thursday, 30'th Apr 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Compared to Estimates, Labcorp (LH) Q1 Earnings: A Look at Key Metrics
10:36am, Thursday, 30'th Apr 2026
The headline numbers for Labcorp (LH) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Labcorp Holdings (LH) Q1 Earnings and Revenues Top Estimates
09:05am, Thursday, 30'th Apr 2026
Labcorp Holdings (LH) came out with quarterly earnings of $4.25 per share, beating the Zacks Consensus Estimate of $4.09 per share. This compares to earnings of $3.84 per share a year ago.
Labcorp raises full-year forecasts on steady diagnostics demand
08:04am, Thursday, 30'th Apr 2026
Labcorp raised its full-year profit and revenue forecast on Thursday after posting quarterly results above expectations as demand for diagnostic testing remained steady.
Q1 2026 revenue was $3.54 billion. The revenue estimate was $3,504.54 million.Diluted EPS was $3.35. The EPS estimate was $3.09.Adjusted EPS was $4.25, up 10.6
Labcorp Announces 2026 First Quarter Results; Raises Full Year 2026 Guidance
06:50am, Thursday, 30'th Apr 2026
Results from Operations for first quarter 2026 versus first quarter 2025: Revenue: $3.54 billion vs. $3.35 billion, up 5.8% Diluted EPS: $3.35 vs.
Wall Street's Insights Into Key Metrics Ahead of Labcorp (LH) Q1 Earnings
10:15am, Wednesday, 29'th Apr 2026
Beyond analysts' top-and-bottom-line estimates for Labcorp (LH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter en
Solventum (SOLV) Reports Next Week: Wall Street Expects Earnings Growth
11:06am, Tuesday, 28'th Apr 2026
Solventum (SOLV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Labcorp Holdings (LH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:04am, Thursday, 23'rd Apr 2026
Labcorp (LH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Labcorp Launches FDA-Approved Companion Diagnostic to Identify Patients with Ovarian Cancer Eligible for KEYTRUDA®
07:00am, Wednesday, 22'nd Apr 2026
BURLINGTON, N.C., April 22, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide availability of Agilent Techno
All You Need to Know About Labcorp (LH) Rating Upgrade to Buy
01:01pm, Tuesday, 21'st Apr 2026
Labcorp (LH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
LH or DHR: Which Is the Better Value Stock Right Now?
12:42pm, Tuesday, 21'st Apr 2026
Investors interested in Medical Services stocks are likely familiar with Labcorp Holdings (LH) and Danaher (DHR). But which of these two stocks is more attractive to value investors?
Labcorp Gears Up to Report Q1 Earnings: What's in Store?
09:56am, Tuesday, 21'st Apr 2026
LH heads into Q1 earnings results with rising diagnostics demand, new partnerships, and AI-driven tools boosting growth across testing and consumer health.
